Cardiaccs AS is developing a disruptive medical device for monitoring in patients undergoing cardiac surgery. Our product is based on a miniaturized accelerometer embedded into a single-use, temporary pacemaker electrode, providing continuous cardiac monitoring and rapid detection of complications such as reduced pumping capacity and limited blood flow.
Cardiovascular related diseases are the leading cause of hospitalization and death worldwide, accounting for more than 17 million deaths per year. Nonsurgical techniques are the most common treatment for heart diseases, but due to an aging population, there is an increase of patients with complex cases where open heart surgeries are required. For these patients, there is an urgent need for better cardiac monitoring to reduce morbidity and mortality.
Cardiaccs was founded by cardiothoracic surgeon and Professor Erik Fosse in 2009 after 8 years of research on placing accelerometers on the heart for assessing cardiac disorders following open heart surgery. The research was performed by the Intervention Centre at Oslo University Hospital, Rikshospitalet together with University College of Southeast Norway, resulting in 4 PhDs and more than 15 scientific publications.